Over the past 20 years a lot has changed within the landscape of oncology therapies. From the introduction of life altering tyrosine kinase inhibitors to the groundbreaking work in CAR-T therapies, progress in the treatment of cancer has evolved, shifting the treatment paradigm. While numerous organizations work to rapidly advance the science behind treating cancer, the patient experience and available support have marginally improved and remain largely unchanged. This conversation between a national KOL in oncology and her patient gives you insight into areas to consider to improve your patient services and support.
- Identify what some of the most impactful changes in oncology patient experience have been
- Discuss manufacturer support that has proven to be the most helpful
- Explore gaps that still exist within the oncology patient experience
- Discover the most valuable factors in pushing the patient experience forward – seen from both the patient and provider perspectives
Click here for additional information and registration details.
Related Content
Evidence Matters 2022
Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.
Achieving Consensus When Everyone is an Expert, but No One Agrees
Join experts from PHAR, Novartis, and Bausch Health for a discussion around the Delphi panels and how the results are used.
Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access
Experts will present opportunities for using agile platforms and fit-for-purpose engagement models that can drive an iterative approach to obtaining payer insights and developing impactful evidence generation strategies.